All Stories

  1. Governing ultra‐processed food and alcohol industries: the presence and role of non‐government organisations in Australia
  2. What is the impact of intellectual property rules on access to medicines? A systematic review
  3. Promoting action on structural drivers of health inequity: principles for policy evaluation
  4. Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership – a qualitative study of policy actors’ views
  5. Universal health coverage for the poorest billion: justice and equity considerations
  6. International Trade Agreements and Global Health: Pathways and Politics
  7. Creating Political Will for Action on Health Equity: Practical Lessons for Public Health Policy Actors
  8. Advancing a health equity agenda across multiple policy domains: a qualitative policy analysis of social, trade and welfare policy
  9. International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
  10. Tackling NCDs: The Need to Address Alcohol Industry Interference and Policy Incoherence Across Sectors Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool"
  11. What Generates Attention to Health in Trade PolicyMaking? Lessons From Success in Tobacco Control and Access to Medicines: A Qualitative Study of Australia and the (Comprehensive and Progressive) Trans-Pacific Partnership
  12. Trade and investment agreements as structural drivers for NCDs: the new public health frontier
  13. Bringing in critical frameworks to investigate agenda-setting for the social determinants of health: Lessons from a multiple framework analysis
  14. A glossary of theories for understanding power and policy for health equity
  15. The nexus between international trade, food systems, malnutrition and climate change
  16. Next Steps for Elevating Health on Trade and Investment Policy Agendas Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention"
  17. Toxic trade: the impact of preferential trade agreements on alcohol imports from Australia in partner countries
  18. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
  19. Public health over private wealth: rebalancing public and private interests in international trade and investment agreements
  20. How can multiple frames enable action on social determinants? Lessons from Australia’s paid parental leave
  21. How do actors with asymmetrical power assert authority in policy agenda-setting? A study of authority claims by health actors in trade policy
  22. An exposé of the realpolitik of trade negotiations: implications for population nutrition
  23. Financial costs associated with monopolies on biologic medicines in Australia
  24. How does policy framing enable or constrain inclusion of social determinants of health and health equity on trade policy agendas?
  25. Power asymmetries, policy incoherence and noncommunicable disease control - a qualitative study of policy actor views
  26. Japan's emerging role in the global pharmaceutical intellectual property regime: A tale of two trade agreements
  27. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines
  28. International medicines governance 1940s to 1970s: lessons for public health
  29. Pharma's next frontier? New threats to public health in the Regional Comprehensive Economic Partnership agreement
  30. Emerging theoretical frameworks for global health governance
  31. Global Health Governance: Framework Convention on Tobacco Control (FCTC), the Doha Declaration, and Democratisation
  32. Pharma's Next Frontier? New Threats to Public Health in the Regional Comprehensive Economic Partnership Agreement